Human technology Styria
Human technology Styria
Human technology Styria
Activities
-
Innovation support bioecosystems
Description
We are the hub of a cluster of around 140 Styrian companies that work for human health.
We act as a hub for contacts, know-how and information for this community.
Our goal is to create economic added value for the cluster community, to further develop the strengths of the region in a targeted manner and thus to improve the international visibility of the location.
We act as a hub for contacts, know-how and information for this community.
Our goal is to create economic added value for the cluster community, to further develop the strengths of the region in a targeted manner and thus to improve the international visibility of the location.
Referent Contact
Margherita Bruni
Business Development Pharma / BioTech
margherita.bruni@human.technology.at
Human technology Styria
Address
Neue Stiftingtalstrasse 2
entrance B, 1st floor
8010 Graz, Styria, Austria
8010 Graz, Styria, Austria
Contact
office@human.technology.at
Description
We are the hub of a cluster of around 140 Styrian companies that work for human health.
We act as a hub for contacts, know-how and information for this community.
Our goal is to create economic added value for the cluster community, to further develop the strengths of the region in a targeted manner and thus to improve the international visibility of the location.
We act as a hub for contacts, know-how and information for this community.
Our goal is to create economic added value for the cluster community, to further develop the strengths of the region in a targeted manner and thus to improve the international visibility of the location.
Matchmaking
Connect with Human technology Styria
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways
Partnership needs
-
Regulatory aspects
-
Business Development
-
Clinical expertise, clinical trials
-
Research & Development
-
Education & Training